Exelead

Exelead is a biopharmaceutical contract development and manufacturing organization (CDMO). Exelead focuses on complex injectable formulations, including lipid nanoparticle (LNP)-based drug delivery technology, which is key to mRNA therapies for Covid-19 and many other indications.